MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Paroxysmal dystonia with phenotypic variability in ECHS1 mutation twin carriers

    G. Bonato, M. Nosadini, S. Andretta, A. Suppiej, A. Leon, S. Sartori, M. Carecchio (Padua, Italy)

    Objective: To describe 2 monozygotic twins carrying biallelic ECHS1 mutations with different clinical phenotypes Background: ECHS1 encodes for a mitochondrial short chain enoyl-CoA hydratase, a…
  • 2022 International Congress

    A clinico-genetic study based on the Innsbruck MSA Registry

    F. Leys, S. Eschlboeck, N. Campese, P. Mahlknecht, M. Peball, V. Sidoroff, R. Granata, V. Bonifati, J. Zschocke, S. Kiechl, W. Poewe, K. Seppi, GK. Wenning, A. Fanciulli (Innsbruck, Austria)

    Objective: To assess family history (FH) for neurodegenerative disorders in people with multiple system atrophy (MSA), compare its prevalence with that of a prospectively recruited…
  • 2022 International Congress

    Resting heart rate variability in Parkinson’s disease with and without freezing of gait

    M. Falla, M. Masé, A. Randi, G. Strapazzon (Rovereto

    Objective: The aim of the study was to investigate heart rate variability (HRV) in Parkinson’s disease (PD) patients with and without freezing of gait (FOG). Background: FOG and…
  • 2022 International Congress

    Neuropsychological evaluation of cerebellar cognitive function in a series of patients with genetically confirmed CANVAS.

    I. Albajar, J. Equiza, A. Lopez-de-Munain, M. Barandiaran, A. Pujol Onofre, J. Ruiz, M. Maneiro, E. Mondragon, A. Vargas, V. Velez, M. Ruiz Sales, E. Verdura Peralta, P. Iruzubieta (San Sebastian, Spain)

    Objective: We aim to present the cerebellar cognitive affective evaluation and phenotypic description of a series of genetically confirmed CANVAS. Background: Cerebellar ataxia, neuropathy and…
  • 2022 International Congress

    Gene Expression Quantification to Assess Frataxin Replacement Therapies in Friedreich’s Ataxia

    M. Baile, D. Schecter, A. Miller, T. Galas, N. Scherer, R. Chen, N. Ruiz, D. Bettoun (Philadelphia, USA)

    Objective: To identify genetic disease and efficacy markers for Friedreich’s ataxia (FRDA) Background: FRDA is a genetic disease caused by decreased expression of the mitochondrial…
  • 2022 International Congress

    Transcutaneous auricular vagal nerve stimulation has frequency depended propensity to improve gait in Parkinson’s disease – a pilot study

    V. van Midden, Z. Pirtošek, G. Brecl Jakob, M. Kojović (Ljubljana, Slovenia)

    Objective: We used wearable inertion motion sensors (WMS) to compare the acute effects of transcutaneous auricular vagal stimulation (taVNS) at 100Hz (taVNS100), 25Hz (taVNS25), and…
  • 2022 International Congress

    Dopa-responsive Combined Dystonia Due to ATP1A3 Gene Variant

    M. Soares, J. Parmera, M. Bezerra (São Paulo, Brazil)

    Objective: To describe a remarkable case of a patient with an atypical ATP1A3 phenotype with levodopa responsiveness, expanding our understanding of this gene mutation. Background: The ATP1A3-spectrum disorders…
  • 2022 International Congress

    Amantadine Is Effective Long-term in Parkinson’s Disease

    S. Park, BS. Jeon (Daejeon, Republic of Korea)

    Objective: This study aimed to investigate the long-term effectiveness of amantadine in patients with PD. Background: Amantadine has been used in the symptomatic treatment of…
  • 2022 International Congress

    Movement Disorders in Hereditary Spastic Paraplegia (HSP): A Systematic Review and Individual Participant Data Meta-Analysis

    SM. Fereshtehnejad, P. Saleh, L. Oliveira, N. Patel, S. Bhowmick, G. Saranza, L. Kalia (Ottawa, Canada)

    Objective: To investigate genotype-phenotype associations in hereditary spastic paraplegia (HSP) with a focus on movement disorders. Background: HSP is a rare genetically-driven disorder associated with…
  • 2022 International Congress

    Reversible secondary parkinsonism attributed to metformin-induced lactic acidosis

    G. Bailey, V. Salinas, R. Dewey, M. Salinas, L. Tardo (Dallas, USA)

    Objective: We describe the case of a 59-year-old man who was evaluated for abnormal imaging and subacute parkinsonism. Background: Secondary parkinsonism can be caused by…
  • « Previous Page
  • 1
  • …
  • 147
  • 148
  • 149
  • 150
  • 151
  • …
  • 153
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley